
Multinostics provides a portable eye-testing device that enables early detection of Alzheimer's disease in a non-invasive way. It blends hardware and software, including AI-assisted analysis, to identify ocular biomarkers linked to Alzheimer's. The solution is a proprietary, integrated platform combining a hardware eye-scanning device with an AI-driven software layer for clinical use. The company aims for scalable, cost-effective diagnostics and has NIH/NIA support to develop an AI-assisted screening platform for AD biomarkers.

Multinostics provides a portable eye-testing device that enables early detection of Alzheimer's disease in a non-invasive way. It blends hardware and software, including AI-assisted analysis, to identify ocular biomarkers linked to Alzheimer's. The solution is a proprietary, integrated platform combining a hardware eye-scanning device with an AI-driven software layer for clinical use. The company aims for scalable, cost-effective diagnostics and has NIH/NIA support to develop an AI-assisted screening platform for AD biomarkers.